Inwound ApS

Private limited companyCVR 39766612VanløseActive

Inwound ApS is a private limited company, based in Vanløse, active in research and experimental development on natural sciences and engineering, founded in 2018. The company made a loss in both 2024 and 2025, most recently DKK 7.7m. Equity grew to DKK 5.9m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 4.1m−108.1% vs. 2024
Net profit−DKK 7.7m−651.2% vs. 2024
EquityDKK 5.9m+66.1% vs. 2024
Employees3latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss grew: from DKK 1m to DKK 7.7m (2024 → 2025).
  • Equity rose 66% (2024 → 2025), to DKK 5.9m.

Employees

  • 6 fewer employees than a year earlier: 3 (07/2026) against 9 (07/2025).

Management and owners, last 24 months

  • New in management: Bent von Eitzen (board member, 14/07/2025), Torsten Dahl Fredelund (board member, 14/07/2025) and Christopher Bromley (board member, 14/07/2025) (+5).
  • Stepped down: Lasse Blirup Snejbjerg (board member, 13/07/2025), Janus Beierholm (ceo, 20/02/2026) and Torsten Dahl Fredelund (chair of the board, 13/07/2025) (+2).

Registrations, last 24 months

  • 14/07/2025: Share capital changed from 192,786 DKK to 215,966 DKK
  • 10/01/2025: Moved to Herlufsholmvej 37, 1, 2720 Vanløse
  • 09/01/2025: Name changed from VulCur MedTech ApS to Inwound ApS
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0DKK 2mDKK 4mDKK 6m202020212022202320242025
EquityNet profit
Financial figures for Inwound ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit−72−857−988−767−1,969−4,096−108.1%
Operating profit (EBIT)−778−2,297−2,515−2,281−3,758−9,249−146.1%
Profit before tax−812−2,679−2,895−2,674−1,020−9,645−846.1%
Net profit−508−2,151−2,341−2,088−1,026−7,707−651.2%
Total assets2,0124,2802,3862,1197,90110,993+39.1%
Equity−1,094−2,245−4,586−5,3113,5305,863+66.1%
Liabilities3,1066,5246,9727,4304,3725,131+17.4%
Cash and cash equivalents9413,1091,1771,0156,2517,460+19.3%
Average number of employees232237+133.3%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 5m−DKK 4m−DKK 3m−DKK 2m−DKK 1mDKK 0DKK 1m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Inwound ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202528/07/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202401/07/2025The companyPDFXBRL
202301/01/2023 – 31/12/202305/07/2024The companyPDFXBRL
202201/01/2022 – 31/12/202210/07/2023The companyPDFXBRL
202101/01/2021 – 31/12/202102/07/2022The companyPDFXBRL
202001/01/2020 – 31/12/202009/07/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02468101208/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 4.1mNo. 370 of 421
Better than 12% of the companies in the industry
EquityDKK 5.9mNo. 168 of 431
Better than 61% of the companies in the industry
Number of employees3No. 173 of 431
Better than 60% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,476of 69,742
Better than 0%
No. 12,761of 69,964
Better than 82%
Same industry and fewer than 20 employees329 companies in the comparison
No. 290of 323
Better than 10%
No. 88of 329
Better than 73%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 33,412of 33,588
Better than 1%
No. 5,439of 33,687
Better than 84%
All companies of type ApS66,508 companies in the comparison
No. 66,157of 66,379
Better than 0%
No. 10,031of 66,505
Better than 85%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Inwound ApS−DKK 4.1m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Inwound ApS−DKK 7.7m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Inwound ApSDKK 5.9m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Inwound ApS3
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • InWound Invest ApS5%
  • Winding Roads ApS10%
  • Akk Biotek Holding ApS50%
  • K Fischer Hansen ApS5%
Inwound ApS

Management

6 active registrations

Executive management

Executive management at Inwound ApS
NameRoleAppointed
Lasse Blirup SnejbjergCEO20/02/2026

Board of directors

Board of directors at Inwound ApS
NameRoleAppointed
Bent von EitzenBoard member14/07/2025
Torsten Dahl FredelundBoard member14/07/2025
Christopher BromleyBoard member14/07/2025
Lasse Blirup SnejbjergBoard member20/02/2026
Carl Morten BilboChair of the board20/02/2026
Founders
Syddansk Innovation ApS, Ivan Holding ApS, Uddannelses- og Forskningsstyrelsen, Akk Biotek Holding ApS
Former management (13)
Former management at Inwound ApS
NameRoleAppointedResigned
Sven Per Magnus ÅgrenBoard member01/08/201813/11/2018
Claus Ivan RehfeldChair of the board01/08/201810/11/2023
Simon Joshua GabrielBoard member01/08/201813/11/2018
Søren Georg JensenBoard member01/08/201807/08/2019
Janus BeierholmCEO01/08/201820/09/2022
Helge Holm-LarsenBoard member07/08/201910/11/2023
Lasse Blirup SnejbjergBoard member15/09/202013/07/2025
Bjørn Broby GlavindBoard member15/06/202129/04/2022
Sophia Sara LethCEO20/09/202201/03/2023
Janus BeierholmCEO01/03/202320/02/2026
Torsten Dahl FredelundChair of the board10/11/202313/07/2025
Lasse Blirup SnejbjergChair of the board14/07/202519/02/2026
Carl Morten BilboBoard member14/07/202519/02/2026

Signing rule: Selskabet tegnes af bestyrelsens formand i forening med en direktør eller af den samlede bestyrelse.

Address and production units

1 active production units

Herlufsholmvej 37
2720 Vanløse

København Municipality · Postcode 2720

Other companies at the address (1)

  • IQinAbox ApSComputer consultancy and computer facilities management
Production units
Production unitAddressEmployeesP number
Inwound ApSHerlufsholmvej 37, 1, 2720 Vanløse31023845098

Purpose

Selskabets formål er at udvikle, kommercialisere, fremstille og sælge et laserapparat til heling af sår.

The purpose is quoted from the register in Danish.

Changes year by year

59 registered events
20267 changesaccounts 1 · management 6
  • Annual report for 2025 published
  • Lasse Blirup Snejbjerg appointed ceo
  • Lasse Blirup Snejbjerg appointed board member
  • Carl Morten Bilbo appointed chair of the board
  • Janus Beierholm stepped down as ceo
  • Carl Morten Bilbo stepped down as board member
  • Lasse Blirup Snejbjerg stepped down as chair of the board
202512 changescapital 1 · management 7 · accounts 1 · address 1 · name 1 · industry 1
  • Share capital changed from 192,786 DKK to 215,966 DKK
  • Bent von Eitzen appointed board member
  • Carl Morten Bilbo appointed board member
  • Lasse Blirup Snejbjerg appointed chair of the board
  • Christopher Bromley appointed board member
  • Torsten Dahl Fredelund appointed board member
  • Torsten Dahl Fredelund stepped down as chair of the board
  • Lasse Blirup Snejbjerg stepped down as board member
  • Annual report for 2024 published
  • Moved to Herlufsholmvej 37, 1, 2720 Vanløse
  • Name changed from VulCur MedTech ApS to Inwound ApS
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
202410 changescapital 3 · ownership 6 · accounts 1
  • Share capital changed from 174,419 DKK to 192,786 DKK
  • WINDING ROADS ApS registered as owner (10%)
  • K Fischer Hansen ApS registered as owner (5%)
  • Akk Biotek Holding ApS registered as owner (50%)
  • WINDING ROADS ApS is no longer registered as owner
  • Akk Biotek Holding ApS is no longer registered as owner
  • Share capital changed from 162,174 DKK to 174,419 DKK
  • InWound Invest ApS registered as owner (5%)
  • Annual report for 2023 published
  • Share capital changed from 158,773 DKK to 162,174 DKK
202310 changesaddress 1 · management 5 · ownership 2 · accounts 1 · capital 1
  • Moved to Søndervigvej 50, 2720 Vanløse
  • Torsten Dahl Fredelund appointed chair of the board
  • Helge Holm-Larsen stepped down as board member
  • Claus Ivan Rehfeld stepped down as chair of the board
  • WINDING ROADS ApS registered as owner (15%)
  • Uddannelses- og Forskningsstyrelsen is no longer registered as owner
  • Annual report for 2022 published
  • Share capital changed from 153,085 DKK to 158,773 DKK
  • Janus Beierholm appointed ceo
  • Sophia Sara Leth stepped down as ceo
20224 changesmanagement 3 · accounts 1
  • Sophia Sara Leth appointed ceo
  • Janus Beierholm stepped down as ceo
  • Annual report for 2021 published
  • Bjørn Broby Glavind stepped down as board member
20213 changesaccounts 1 · management 1 · capital 1
  • Annual report for 2020 published
  • Bjørn Broby Glavind appointed board member
  • Share capital changed from 149,351 DKK to 153,085 DKK
20201 changemanagement 1
  • Lasse Blirup Snejbjerg appointed board member
20192 changesmanagement 2
  • Helge Holm-Larsen appointed board member
  • Søren Georg Jensen stepped down as board member
201810 changesmanagement 7 · founded 1 · ownership 2
  • Sven Per Magnus Ågren stepped down as board member
  • Simon Joshua Gabriel stepped down as board member
  • Registered as VulCur MedTech ApS
  • Sven Per Magnus Ågren appointed board member
  • Claus Ivan Rehfeld appointed chair of the board
  • Janus Beierholm appointed ceo
  • Søren Georg Jensen appointed board member
  • Simon Joshua Gabriel appointed board member
  • Uddannelses- og Forskningsstyrelsen registered as owner (10%)
  • Akk Biotek Holding ApS registered as owner (66.67%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction